• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

顺铂负载的多壁碳纳米管通过抑制上皮-间质转化逆转非小细胞肺癌的耐药性。

Cisplatin loaded multiwalled carbon nanotubes reverse drug resistance in NSCLC by inhibiting EMT.

作者信息

Qi Yuxin, Yang Wenping, Liu Shuang, Han Fanjie, Wang Haibin, Zhao Yonghong, Zhou Yufa, Zhou Daijun

机构信息

Department of Respiratory Medicine, Jinan People's Hospital Affiliated to Shandong First Medical University, Jinan, 271199, China.

Department of Oncology, General Hospital of Western Theater Command of PLA, Chengdu, 610083, China.

出版信息

Cancer Cell Int. 2021 Jan 25;21(1):74. doi: 10.1186/s12935-021-01771-9.

DOI:10.1186/s12935-021-01771-9
PMID:33494783
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7836500/
Abstract

BACKGROUND

Lung cancer is one of the important health threats worldwide, of which 5-year survival rate is less than 15%. Non-small-cell lung cancer (NSCLC) accounts for about 80% of all lung cancer with high metastasis and mortality.

METHODS

Cisplatin loaded multiwalled carbon nanotubes (Pt-MWNTS) were synthesized and used to evaluate the anticancer effect in our study. The NSCLC cell lines A549 (cisplatin sensitive) and A549/DDP (cisplatin resistant) were used in our in vitro assays. MTT was used to determine Cancer cells viability and invasion were measured by MTT assay and Transwell assay, respectively. Apoptosis and epithelial-mesenchymal transition related marker proteins were measured by western blot. The in vivo anti-cancer effect of Pt-MWNTs were performed in male BALB/c nude mice (4-week old).

RESULTS

Pt-MWNTS were synthesized and characterized by X-ray diffraction, Raman, FT-IR spectroscopy and scan electron microscopy. No significant cytotoxicity of MWNTS was detected in both A549/DDP and A549 cell lines. However, Pt-MWNTS showed a stronger inhibition effect on cell growth than free cisplatin, especially on A549/DDP. We found Pt-MWNTS showed higher intracellular accumulation of cisplatin in A549/DDP cells than free cisplatin and resulted in enhanced the percent of apoptotic cells. Western blot showed that application of Pt-MWNTS can significantly upregulate the expression level of Bax, Bim, Bid, Caspase-3 and Caspase-9 while downregulate the expression level of Bcl-2, compared with free cisplatin. Moreover, the expression level of mesenchymal markers like Vimentin and N-cadherin was more efficiently reduced by Pt-MWNTS treatment in A549/DDP cells than free cisplatin. In vivo study in nude mice proved that Pt-MWNTS more effectively inhibited tumorigenesis compared with cisplatin, although both of them had no significant effect on body weight.

CONCLUSION

Pt-MWNT reverses the drug resistance in the A549/DDP cell line, underlying its possibility of treating NSCLC with cisplatin resistance.

摘要

背景

肺癌是全球重要的健康威胁之一,其5年生存率低于15%。非小细胞肺癌(NSCLC)约占所有肺癌的80%,具有高转移率和高死亡率。

方法

在本研究中合成了负载顺铂的多壁碳纳米管(Pt-MWNTS)并用于评估其抗癌效果。体外实验使用了NSCLC细胞系A549(顺铂敏感型)和A549/DDP(顺铂耐药型)。采用MTT法测定癌细胞活力,分别通过MTT法和Transwell法检测侵袭能力。通过蛋白质免疫印迹法检测凋亡及上皮-间质转化相关标记蛋白。在4周龄雄性BALB/c裸鼠体内进行Pt-MWNTs的抗癌效果实验。

结果

通过X射线衍射、拉曼光谱、傅里叶变换红外光谱和扫描电子显微镜对合成的Pt-MWNTS进行了表征。在A549/DDP和A549细胞系中均未检测到MWNTS有明显的细胞毒性。然而,Pt-MWNTS对细胞生长的抑制作用比游离顺铂更强,尤其是对A549/DDP细胞。我们发现Pt-MWNTS在A549/DDP细胞中顺铂的细胞内积累量比游离顺铂更高,并导致凋亡细胞百分比增加。蛋白质免疫印迹显示,与游离顺铂相比,应用Pt-MWNTS可显著上调Bax、Bim、Bid、Caspase-3和Caspase-9的表达水平,同时下调Bcl-2的表达水平。此外,在A549/DDP细胞中,Pt-MWNTS处理比游离顺铂更有效地降低了波形蛋白和N-钙黏蛋白等间质标记物的表达水平。裸鼠体内研究证明,与顺铂相比,Pt-MWNTS能更有效地抑制肿瘤发生,尽管它们对体重均无显著影响。

结论

Pt-MWNT可逆转A549/DDP细胞系中的耐药性,这表明其具有治疗顺铂耐药NSCLC的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7869/7836500/4739ddc11c17/12935_2021_1771_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7869/7836500/c59a437a68f4/12935_2021_1771_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7869/7836500/774ed70f1eb9/12935_2021_1771_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7869/7836500/7db5b481a120/12935_2021_1771_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7869/7836500/c0f75c0d3d6a/12935_2021_1771_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7869/7836500/1e5cad2f8e2d/12935_2021_1771_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7869/7836500/4739ddc11c17/12935_2021_1771_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7869/7836500/c59a437a68f4/12935_2021_1771_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7869/7836500/774ed70f1eb9/12935_2021_1771_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7869/7836500/7db5b481a120/12935_2021_1771_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7869/7836500/c0f75c0d3d6a/12935_2021_1771_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7869/7836500/1e5cad2f8e2d/12935_2021_1771_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7869/7836500/4739ddc11c17/12935_2021_1771_Fig6_HTML.jpg

相似文献

1
Cisplatin loaded multiwalled carbon nanotubes reverse drug resistance in NSCLC by inhibiting EMT.顺铂负载的多壁碳纳米管通过抑制上皮-间质转化逆转非小细胞肺癌的耐药性。
Cancer Cell Int. 2021 Jan 25;21(1):74. doi: 10.1186/s12935-021-01771-9.
2
Long Non-Coding RNA SPRY4-IT1 Reverses Cisplatin Resistance by Downregulating MPZL-1 via Suppressing EMT in NSCLC.长链非编码RNA SPRY4-IT1通过抑制非小细胞肺癌中的上皮-间质转化下调MPZL-1来逆转顺铂耐药性。
Onco Targets Ther. 2020 Apr 2;13:2783-2793. doi: 10.2147/OTT.S232769. eCollection 2020.
3
Cathepsin L upregulation-induced EMT phenotype is associated with the acquisition of cisplatin or paclitaxel resistance in A549 cells.组织蛋白酶L上调诱导的上皮-间质转化表型与A549细胞中顺铂或紫杉醇耐药性的获得有关。
Acta Pharmacol Sin. 2016 Dec;37(12):1606-1622. doi: 10.1038/aps.2016.93. Epub 2016 Nov 14.
4
Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line.抑制微小RNA-196a可能会逆转A549/DDP非小细胞肺癌细胞系的顺铂耐药性。
Tumour Biol. 2016 Feb;37(2):2387-94. doi: 10.1007/s13277-015-4017-7. Epub 2015 Sep 16.
5
LncRNA LINC01116 Contributes to Cisplatin Resistance in Lung Adenocarcinoma.长链非编码RNA LINC01116促进肺腺癌顺铂耐药
Onco Targets Ther. 2020 Sep 22;13:9333-9348. doi: 10.2147/OTT.S244879. eCollection 2020.
6
Silence of  lncRNA UCA1 rescues drug resistance of cisplatin to non-small-cell lung cancer cells.长链非编码 RNA UCA1 的沉默挽救了顺铂对非小细胞肺癌细胞的耐药性。
J Cell Biochem. 2019 Jun;120(6):9243-9249. doi: 10.1002/jcb.28200. Epub 2019 Jan 16.
7
Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis.干扰高迁移率族蛋白B1(HMGB1)可通过抑制HMGB1介导的细胞自噬和诱导细胞凋亡来增加对化疗药物的敏感性。
Tumour Biol. 2015 Nov;36(11):8585-92. doi: 10.1007/s13277-015-3617-6. Epub 2015 Jun 4.
8
Reversal of multidrug resistance by cisplatin-loaded magnetic Fe3O4 nanoparticles in A549/DDP lung cancer cells in vitro and in vivo.顺铂载磁 Fe3O4 纳米粒逆转 A549/DDP 肺癌细胞多药耐药的体内外研究。
Int J Nanomedicine. 2013;8:1867-77. doi: 10.2147/IJN.S43752. Epub 2013 May 9.
9
Effects of VBMDMP on the reversal of cisplatin resistance in human lung cancer A549/DDP cells.VBMDMP对人肺癌A549/DDP细胞顺铂耐药逆转的影响。
Oncol Rep. 2015 Jan;33(1):372-82. doi: 10.3892/or.2014.3607. Epub 2014 Nov 13.
10
A monoclonal antibody against basic fibroblast growth factor attenuates cisplatin resistance in lung cancer by suppressing the epithelial-mesenchymal transition.一种针对碱性成纤维细胞生长因子的单克隆抗体通过抑制上皮-间充质转化来减弱肺癌的顺铂耐药性。
Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221105134. doi: 10.1177/03946320221105134.

引用本文的文献

1
Nanotechnology in cancer treatment: revolutionizing strategies against drug resistance.癌症治疗中的纳米技术:革新抗耐药性策略
Front Bioeng Biotechnol. 2025 Apr 30;13:1548588. doi: 10.3389/fbioe.2025.1548588. eCollection 2025.
2
Groenlandicine enhances cisplatin sensitivity in cisplatin-resistant osteosarcoma cells through the BAX/Bcl-2/Caspase-9/Caspase-3 pathway.格陵兰icine通过BAX/Bcl-2/Caspase-9/Caspase-3途径增强顺铂耐药骨肉瘤细胞对顺铂的敏感性。
J Bone Oncol. 2024 Aug 24;48:100631. doi: 10.1016/j.jbo.2024.100631. eCollection 2024 Oct.
3
Gelatin-Functionalized Carbon Nanotubes Loaded with Cisplatin for Anti-Cancer Therapy.

本文引用的文献

1
Management of Late Relapses After Chemotherapy in Testicular Cancer: Optimal Outcomes with Dose-intense Salvage Chemotherapy and Surgery.化疗后睾丸癌晚期复发的治疗:强化挽救化疗和手术可获得最佳疗效。
Eur Urol Focus. 2021 Jul;7(4):835-842. doi: 10.1016/j.euf.2020.04.001. Epub 2020 May 4.
2
Upregulation of cell division cycle 20 in cisplatin resistance-induced epithelial-mesenchymal transition in osteosarcoma cells.细胞分裂周期蛋白20在顺铂耐药诱导骨肉瘤细胞上皮-间质转化中的上调
Am J Transl Res. 2020 Apr 15;12(4):1309-1318. eCollection 2020.
3
Analysis of Lung Adenocarcinoma Subtypes Based on Immune Signatures Identifies Clinical Implications for Cancer Therapy.
负载顺铂的明胶功能化碳纳米管用于抗癌治疗
Polymers (Basel). 2023 Aug 8;15(16):3333. doi: 10.3390/polym15163333.
4
Carbon Nanomaterials (CNMs) in Cancer Therapy: A Database of CNM-Based Nanocarrier Systems.癌症治疗中的碳纳米材料(CNMs):基于CNM的纳米载体系统数据库
Pharmaceutics. 2023 May 19;15(5):1545. doi: 10.3390/pharmaceutics15051545.
5
Carbon Nanotubes as Carriers in Drug Delivery for Non-Small Cell Lung Cancer, Mechanistic Analysis of Their Carcinogenic Potential, Safety Profiling and Identification of Biomarkers.碳纳米管作为非小细胞肺癌药物递送载体:致癌潜力的机制分析、安全性评估和生物标志物鉴定。
Int J Nanomedicine. 2022 Dec 8;17:6157-6180. doi: 10.2147/IJN.S384592. eCollection 2022.
6
Role and Mechanism of Exosome-Derived Long Noncoding RNA HOTAIR in Lung Cancer.外泌体来源的长链非编码RNA HOTAIR在肺癌中的作用及机制
ACS Omega. 2021 Jun 29;6(27):17217-17227. doi: 10.1021/acsomega.1c00905. eCollection 2021 Jul 13.
基于免疫特征的肺腺癌亚型分析确定癌症治疗的临床意义。
Mol Ther Oncolytics. 2020 Apr 7;17:241-249. doi: 10.1016/j.omto.2020.03.021. eCollection 2020 Jun 26.
4
LncRNA NR2F1-AS1 promotes proliferation and metastasis of ESCC cells via regulating EMT.长链非编码 RNA NR2F1-AS1 通过调节 EMT 促进 ESCC 细胞的增殖和转移。
Eur Rev Med Pharmacol Sci. 2020 Apr;24(7):3686-3693. doi: 10.26355/eurrev_202004_20831.
5
YIPF2 promotes chemotherapeutic agent-mediated apoptosis via enhancing TNFRSF10B recycling to plasma membrane in non-small cell lung cancer cells.YIPF2 通过增强 TNFRSF10B 向非小细胞肺癌细胞质膜的再循环促进化疗药物介导的细胞凋亡。
Cell Death Dis. 2020 Apr 17;11(4):242. doi: 10.1038/s41419-020-2436-x.
6
Downregulation of the circadian rhythm regulator HLF promotes multiple-organ distant metastases in non-small cell lung cancer through PPAR/NF-κb signaling.节律调节因子 HLF 的下调通过 PPAR/NF-κb 信号通路促进非小细胞肺癌的多器官远处转移。
Cancer Lett. 2020 Jul 10;482:56-71. doi: 10.1016/j.canlet.2020.04.007. Epub 2020 Apr 11.
7
MWCNT-mediated combinatorial photothermal ablation and chemo-immunotherapy strategy for the treatment of melanoma.多壁碳纳米管介导的组合光热消融与化学免疫疗法治疗黑色素瘤的策略
J Mater Chem B. 2020 May 21;8(19):4245-4258. doi: 10.1039/c9tb02238d. Epub 2020 Apr 13.
8
Cyclooxygenase-2 promotes ovarian cancer cell migration and cisplatin resistance via regulating epithelial mesenchymal transition.环氧化酶-2 通过调节上皮间质转化促进卵巢癌细胞迁移和顺铂耐药性。
J Zhejiang Univ Sci B. 2020;21(4):315-326. doi: 10.1631/jzus.B1900445.
9
Ivermectin Augments the In Vitro and In Vivo Efficacy of Cisplatin in Epithelial Ovarian Cancer by Suppressing Akt/mTOR Signaling.伊维菌素通过抑制 Akt/mTOR 信号通路增强顺铂在卵巢上皮性癌细胞系和体内的抗肿瘤活性。
Am J Med Sci. 2020 Feb;359(2):123-129. doi: 10.1016/j.amjms.2019.11.001. Epub 2019 Nov 9.
10
Pharmacological and toxicological aspects of carbon nanotubes (CNTs) to vascular system: A review.碳纳米管(CNTs)对血管系统的药理和毒理学方面:综述。
Toxicol Appl Pharmacol. 2019 Dec 15;385:114801. doi: 10.1016/j.taap.2019.114801. Epub 2019 Nov 1.